GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (STU:LWA) » Definitions » Return-on-Tangible-Equity

Eco Animal Health Group (STU:LWA) Return-on-Tangible-Equity : -7.79% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Eco Animal Health Group Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Eco Animal Health Group's annualized net income for the quarter that ended in Sep. 2024 was €-4.04 Mil. Eco Animal Health Group's average shareholder tangible equity for the quarter that ended in Sep. 2024 was €51.90 Mil. Therefore, Eco Animal Health Group's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 was -7.79%.

The historical rank and industry rank for Eco Animal Health Group's Return-on-Tangible-Equity or its related term are showing as below:

STU:LWA' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1.47   Med: 15.98   Max: 29.04
Current: 1.49

During the past 13 years, Eco Animal Health Group's highest Return-on-Tangible-Equity was 29.04%. The lowest was -1.47%. And the median was 15.98%.

STU:LWA's Return-on-Tangible-Equity is ranked worse than
63.53% of 913 companies
in the Drug Manufacturers industry
Industry Median: 6.4 vs STU:LWA: 1.49

Eco Animal Health Group Return-on-Tangible-Equity Historical Data

The historical data trend for Eco Animal Health Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group Return-on-Tangible-Equity Chart

Eco Animal Health Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.39 17.89 -1.49 2.06 2.29

Eco Animal Health Group Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.37 -1.31 -5.72 10.48 -7.79

Competitive Comparison of Eco Animal Health Group's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eco Animal Health Group's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Eco Animal Health Group's Return-on-Tangible-Equity falls into.



Eco Animal Health Group Return-on-Tangible-Equity Calculation

Eco Animal Health Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=1.225/( (53.993+53.001 )/ 2 )
=1.225/53.497
=2.29 %

Eco Animal Health Group's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2024 )  (Q: Mar. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Mar. 2024 )(Q: Sep. 2024 )
=-4.044/( (53.001+50.807)/ 2 )
=-4.044/51.904
=-7.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Eco Animal Health Group  (STU:LWA) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Eco Animal Health Group Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Eco Animal Health Group's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Eco Animal Health Group Business Description

Traded in Other Exchanges
Address
100 High street, The Grange, Southgate, London, GBR, N14 6BN
Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.

Eco Animal Health Group Headlines

No Headlines